Sinistral portal hypertension after pancreaticoduodenectomy with splenic vein resection: Pathogenesis and its prevention

13Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

To achieve curative resection for pancreatic cancer during pancreaticoduodenectomy (PD), extensive portal vein (PV) resection, including porto-mesenterico-splenic confluence (PMSC), may sometimes be necessary if the tumor is close to the portal venous system. Recently, this extended resection has been widely accepted in high-volume centers for pancreatic resection due to its favorable outcomes compared with non-operative treatment. However, in patients with long-term survival, sinistral portal hypertension (SPH) occurs as a late-onset postoperative complication. These patients present gastrointestinal varices due to congested venous flow from the spleen, which may cause critical variceal bleeding. Since the prognosis of patients with pancreatic cancer has improved, owing to the development of chemotherapy and surgical techniques, SPH is no longer a negligible matter in the field of pancreatic cancer surgery. This review clarifies the pathogenesis and frequency of SPH after PD through PMSC resection and discusses its prediction and prevention.

Cite

CITATION STYLE

APA

Ono, Y., Inoue, Y., Kato, T., Matsueda, K., Oba, A., Sato, T., … Takahashi, Y. (2021, November 1). Sinistral portal hypertension after pancreaticoduodenectomy with splenic vein resection: Pathogenesis and its prevention. Cancers. MDPI. https://doi.org/10.3390/cancers13215334

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free